Patrick Van Dreden

Thrombosis and Pregnancy in Congenital Deficiencies in AT III, Protein C or Protein S: Study of 78 Women

J. Conard, M.H. Horellou, Patrick Van Dreden et al. · Thrombosis and Haemostasis · 1990 · 284 citations

Gynecology, Defects, High-risk Pregnancy +20

HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease

Barry W. Festoff, Ravi K. Sajja, Patrick Van Dreden et al. · Journal of Neuroinflammation · 2016 · 202 citations · Full text

The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles

Grigoris Gerotziafas, Patrick Van Dreden, Mourad Chaari et al. · Thrombosis and Haemostasis · 2012 · 69 citations

Immunohematology, Immunology, Blood Cell +23

Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: New and useful markers for pre-eclampsia?

Aurélie Rousseau, Rémi Favier, Patrick Van Dreden · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2009 · 68 citations

Thrombosis, Hypertension, Soluble Thrombomodulin Activity +14

SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia

Ismaı̈l Elalamy, Grigoris Gerotziafas, Sonia Alamowitch et al. · Thrombosis and Haemostasis · 2021 · 61 citations · Full text

Immunodeficiencies, Expert Consensus, Immunology +22